Tuesday 9 June 2026

One To Watch

Attovia Therapeutics

A Californian biotech company developing spatially optimized biparatopic biologics.

Company Overview

Want to Update your Company's Profile?


Latest Attovia Therapeutics News

Attovia Therapeutics closes $90 million Series C financing
15 April 2025
Attovia raises $105 million
9 May 2024
More Attovia Therapeutics news >


Today's issue

MHRA nod for Janssen’s Imaavy
Biotechnology
MHRA nod for Janssen’s Imaavy
9 June 2026
Pharmaceutical
MHRA launches AI sandbox to support medicines development and drug safety
9 June 2026
Biotechnology
AmMax Bio licenses ADC technology from Lonza
9 June 2026
Biotechnology
ARK Invest backs Cellares with $20 million as automated cell therapy manufacturing gains momentum
9 June 2026
Pharmaceutical
AlzeCure inks deal with Lilly for Alzheimer’s project
9 June 2026
Pharmaceutical
AstraZeneca advances oral GLP-1 elecoglipron into Phase III
9 June 2026
Biotechnology
Cartesian strikes licensing agreement with WestGene
9 June 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze